Cargando…

Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway

Trimethylamine-N-oxide (TMAO), an important gut microbiota (GM)-derived metabolite, has been shown to be abnormally increased in osteoporosis. However, the role and underlying mechanism of TMAO in regulating bone loss during osteoporosis have not been fully investigated. In the current study, we fou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ning, Hao, Yongqiang, Fu, Lingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573743/ https://www.ncbi.nlm.nih.gov/pubmed/36235607 http://dx.doi.org/10.3390/nu14193955

Ejemplares similares

Dauricine Protects from LPS-Induced Bone Loss via the ROS/PP2A/NF-κB Axis in Osteoclasts
por: Park, Hyun-Jung, et al.
Publicado: (2020)

Gut microbiota dependant trimethylamine N-oxide and hypertension
por: Mutengo, Katongo H., et al.
Publicado: (2023)

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast‐induced bone loss by modulating NF‐κB signalling pathway
por: Hu, Bin, et al.
Publicado: (2019)

The Polyphenol Fisetin Protects Bone by Repressing NF-κB and MKP-1-Dependent Signaling Pathways in Osteoclasts
por: Léotoing, Laurent, et al.
Publicado: (2013)

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
por: Liu, Huijiang, et al.
Publicado: (2022)

Ceritinib (LDK378) prevents bone loss via suppressing Akt and NF-κB-induced osteoclast formation
por: He, Wenxin, et al.
Publicado: (2022)

Trimethylamine N-Oxide Does Not Impact Viability, ROS Production, and Mitochondrial Membrane Potential of Adult Rat Cardiomyocytes
por: Querio, Giulia, et al.
Publicado: (2019)

Trimethylamine N-Oxide: The Good, the Bad and the Unknown
por: Velasquez, Manuel T., et al.
Publicado: (2016)

Trimethylamine N-oxide in atrial fibrillation progression
por: Büttner, Petra, et al.
Publicado: (2020)

Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021)

Influence of Trimethylamine N-Oxide on Platelet Activation
por: Emonds, Julian Josef, et al.
Publicado: (2022)

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF‐κB pathway
por: Li, Yajun, et al.
Publicado: (2022)

Oxidation of trimethylamine to trimethylamine N-oxide facilitates high hydrostatic pressure tolerance in a generalist bacterial lineage
por: Qin, Qi-Long, et al.
Publicado: (2021)

Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice
por: Kuka, Janis, et al.
Publicado: (2020)

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease
por: He, Wei, et al.
Publicado: (2020)

STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice
por: MacLauchlan, Susan, et al.
Publicado: (2023)

Simultaneous Measurement of Urinary Trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) by Liquid Chromatography–Mass Spectrometry
por: Jia, Xun, et al.
Publicado: (2020)

Higher Trimethylamine-N-Oxide Plasma Levels with Increasing Age Are Mediated by Diet and Trimethylamine-Forming Bacteria
por: Rath, Silke, et al.
Publicado: (2021)

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts
por: Greenblatt, Matthew B., et al.
Publicado: (2015)

Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2020)

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
por: Jiang, Shan, et al.
Publicado: (2021)

Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke
por: Sun, Taoping, et al.
Publicado: (2021)

Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018)

Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
por: Zhu, Yingqian, et al.
Publicado: (2020)

Polycentric binding in complexes of trimethylamine-N-oxide with dihalogens
por: Zarechnaya, Olga M., et al.
Publicado: (2021)

Gut-Flora-Dependent Metabolite Trimethylamine-N-Oxide Promotes Atherosclerosis-Associated Inflammation Responses by Indirect ROS Stimulation and Signaling Involving AMPK and SIRT1
por: Zhou, Sa, et al.
Publicado: (2022)

Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway
por: Chawalitpong, Supatta, et al.
Publicado: (2018)

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation
por: Wei, Rongfang, et al.
Publicado: (2023)

Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways
por: Sun, Kaiqiang, et al.
Publicado: (2022)

Nicorandil Inhibits Osteoclast Formation Base on NF-κB and p-38 MAPK Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
por: Xu, Shenggui, et al.
Publicado: (2021)

PKCθ Regulates Pituitary Adenoma Bone Invasion by Activating Osteoclast in NF-κB/IL-1β-Dependent Manner
por: Wang, Quanji, et al.
Publicado: (2023)

Bone loss: Factors that regulate osteoclast differentiation - an update
por: Roux, Sophie, et al.
Publicado: (2000)

Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-κB Pathway
por: Odes-Barth, Shlomit, et al.
Publicado: (2020)

Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke
por: Rexidamu, Maimaiti, et al.
Publicado: (2019)

Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
por: Nam, Hyo Suk
Publicado: (2019)

Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
por: Papandreou, Christopher, et al.
Publicado: (2020)

Loop Diuretics Inhibit Renal Excretion of Trimethylamine N-Oxide
por: Li, Daniel Y., et al.
Publicado: (2021)

Unraveling the Effects of Trimethylamine N-Oxide on Stroke: “The lower, the better?”
por: Yamashita, Tomoya, et al.
Publicado: (2021)

Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
por: Fretts, Amanda M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ujbgolfe2edm7eaagc5ud8r5td